Luis Vega Batista v. HHS - MMR, idiopathic thrombocytopenic purpura (ITP) (2026)

On October 26, 2023, Luis Vega Batista filed a petition alleging that a measles-mumps-rubella (MMR) vaccine administered on October 30, 2020 caused idiopathic thrombocytopenic purpura (ITP). Respondent filed a Rule 4(c) report on March 6, 2026 agreeing that the claim was appropriate for compensation as a Table ITP injury.

Respondent agreed that Mr. Vega Batista's ITP began within the Table timeframe of 7 to 42 days after MMR vaccination, that he demonstrated clinical manifestations of ITP, that his serum platelet count was less than 50,000, and that there was no applicable exclusion.

Special Master Mindy Michaels Roth, through Special Master Young's captioned ruling, granted entitlement on March 10, 2026. The decision resolved entitlement only.

Damages had not yet been awarded in the public record reviewed for this update.